By Josh Beckerman 
 

The initial public offering of Elanco Animal Health Inc. (ELAN), a unit of Eli Lilly & Co. (LLY), priced above its expected range on Wednesday.

The 62.9 million-share IPO priced at $24, compared with the projected range of $20 to $23.

Elanco reported revenue of $2.89 billion in 2017, with a pro forma net loss of $378.9 million.

 

Write to Josh Beckerman at josh.beckerman@wsj.com

 

(END) Dow Jones Newswires

September 19, 2018 17:37 ET (21:37 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Eli Lilly Charts.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Eli Lilly Charts.